According to the trial results, Jardiance reduces the risk of death or hospitalisation due to heart failure for diabetic and non-diabetic patients with HFpEF.
The Israel Health Ministry is examining a small number of cases related to inflammation of the heart muscle in individuals inoculated with Pfizer and BioNtech’s Covid-19 vaccine.
There is growing evidence that about 10% of people with Covid-19 will go on to experience 'long Covid', where symptoms such as fatigue, shortness of breath, fevers, gastrointestinal issues, sleep disorders, 'brain fog', anxiety, post-traumatic...
As February is American Heart Month in the US, GlobalData epidemiologists are highlighting findings from a nationwide study on premature heart disease and cancer-related deaths in young women, published mid-February in the 'European Heart Journal...
Human tissue bioengineering biotech Humacyte has entered into a business combination agreement with special purpose acquisition company (SPAC) Alpha Healthcare Acquisition Corp (AHAC).
US Judge Dean Ochiai has ordered Bristol-Myers Squibb (BMS) and Sanofi to pay over $834m to the state of Hawaii for illegally marketing their blood-thinning drug Plavix.
China’s National Medical Products Administration (NMPA) has approved AstraZeneca’s Forxiga (dapagliflozin) for heart failure with reduced ejection fraction (HFrEF) in adults with and without type-2 diabetes.